The CE Shop | January 05, 2023
People in Connecticut who want to start a new career in real estate, a thriving profession with steady market demand, now have an option for flexible learning to grab a full-time job! The CE Shop is the first leading provider of online professional education to offer this form of flexible learning for the Connecticut Salesperson Pre-Licensing course.
The Connecticut Salesperson Pre-Licensing course, in total, takes 60 hours and is made up of several learning modules. Students can finish the course at their own pace using the company's self-paced delivery method, attend live online classes, or do a mix of both.
The state of Connecticut sets no time limit on the final exam, and you can take the Salesperson Pre-Licensing Exam as often as you want. Most people can finish their real estate education and pass their examinations within a month or two. They can then start a career in real estate and earn the average real estate agent salary in Connecticut, which is $90,726 per year, according to Indeed.com. The real estate market in Connecticut is one of the best in the country, and The CE Shop is an ideal place to learn about your next career.
After taking the Connecticut Pre-Licensing course and passing the final exam, a new real estate license is accepted in Alabama, Florida, Colorado, Georgia, Illinois, Indiana, Massachusetts, Mississippi, Nebraska, New York, Oklahoma, Ohio, and Rhode Island. This is because of a reciprocity agreement between the states. All applicants from Florida, Illinois, Indiana, and Ohio, and those from reciprocal states who still need to take a written test, must take the State Portion of the Connecticut Real Estate Examination.
About The CE Shop
Based out of Greenwood Village, Colorado, The CE Shop is the leading provider of online professional education with mortgage and real estate courses in the United States. It is consistently named one of Colorado's fastest-growing private companies and a top place to work. It believes that good education can make a difference; thus, it keeps providing a good education for professionals all over the country, whether they are already working in their field or want to start a new one.
Manchester University | November 03, 2022
GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University (MU) for pharmacogenomics education. Together, GenXys and MU will help drive global awareness and education of PGx-informed prescribing decisions in support of expanding PGx adoption and pending legislation in the U.S., including the Right Drug Dose Now Act. MU, located in northern Indiana, is a leading national academic institution with a strong educational and research stream in pharmacogenetics. With on-campus, online, and dual (PharmD/MS in PGx) degree programs, as well as a Graduate Certificate in PGx, MU typically has an annual PGx enrollment of 60 to 70 students. The partnership will enable GenXys' expertise and proprietary algorithms in genomics and clinical knowledge to support the expansion of genetically informed medication review capabilities in MU's educational and research space. MU will now be able to integrate GenXys' award-winning Clinical Decision Support Systems (CDSS), incorporating PGx with other patient data points through embedded translation and interpretation in specific degree programs. This will lead to students further learning appropriate evidence-based precision prescribing options for patients, ultimately leading to better health outcomes and empowering the next generation of clinicians to seamlessly utilize PGx in patient care. As a national leader in pharmacogenetic and clinical education, Manchester University looks to partner with leading-edge technology companies that further the advancement of PGx for better health outcomes, says David Kisor, PharmD, FCP, Professor of Pharmaceutical Sciences and Pharmacogenomics, Director of Pharmacogenomics at MU. "It is recognized that more than 95 percent of the population has at least one PGx variant, and large percentages of patients receiving medications across therapeutic areas do not respond adequately with an initial medication leading to trial-and-error prescribing. Additionally, the consequences and treatments of adverse drug events may cost more than $30 billion annually in the U.S.," Dr. Kisor adds. "By formally measuring the effect of automatic PGx inclusion in CDSS tools in education as well as incorporating GenXys' precision prescribing platform into our advanced courses, we aim to produce the most knowledgeable and equipped individuals who will apply PGx optimally across healthcare settings. Integration of the precision prescribing platform offered by GenXys into the educational content of MU will accelerate the knowledge uptake of PGx in prescribing decisions for the next generation of clinicians and other healthcare professionals.
"By working with a stellar academic university like MU, we are able to demonstrate the advantage of including PGx in clinical care for clinicians across different career levels ,There are so many advantages to equipping students and trainees with leading-edge tools and knowledge—the future is looking bright for precision medicine!"
Bernard Esquivel, MD, PhD, Chief Medical Officer of GenXys.
Auto-analysis of genetic information with other medication interaction points is helping to transform the centuries-old trial-and-error approach to prescribing to one of accuracy. PGx is all about personalized, safe, and appropriate medication options being available at any point of care. When integrated into smart algorithms with other data points, PGx is a critical part of proactive healthcare delivering precision medicine to everyone and leveling up healthcare inequality. MU is at the educational edge of changing day-to-day healthcare, and the partnership with GenXys is a model of commercial and academic integration that supports pending national legislation to provide better population healthcare, improve patient safety, and reduce healthcare costs.
About GenXys Health Care Systems
GenXys, with a presence across North America, provides the world's most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare's biggest challenges: inappropriate ("trial-and-error") prescribing. GenXys' clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America. Ongoing global clinical studies are paving the way into geographical markets to enable GenXys to realize its vision of making every prescription better with its software to increase patient safety, improve population health, and reduce healthcare costs. https://www.genxys.com/
About Manchester University
Manchester University, in North Manchester and Fort Wayne, Ind., provides vibrant and transformative student experiences. Manchester University respects the infinite worth of every individual and graduates persons of ability and conviction who draw upon their education and faith to lead principled, productive, and compassionate lives that improve the human condition.
Pixotope | December 07, 2022
Pixotope, the leading software platform for end-to-end realtime virtual production solutions, is thrilled to announce that the University of Gloucestershire’s School of Creative Industries has officially joined the Pixotope Education Program, the company’s educational and community-building initiative designed to help enable the next generation of Virtual Production talent.
“University of Gloucestershire is an incredible partner for the Pixotope Education Program. Our relationship is founded on open communication about the needs of today's virtual production students and how we can work together to meet those needs,”
Pixotope Education Program Manager, Carina Schoo.
Based out of the University’s Cheltenham, U.K. campus, the school’s state-of-the-art Media Centre features the same facilities used by media production professionals around the world. The bi-directional relationship between the School of Creative Industries and Pixotope ensures that students get hands-on experience with the technology and workflows they need to be successful in their careers in virtual production. Faced with rapidly evolving technology and production techniques, the School of Creative Industries at University of Gloucestershire needed to ensure that its courses remained ahead of the curve in terms of technological innovation. The Pixotope Education Program delivers this by providing direct access to the tools and industry experts powering virtual production today. Our partnership with Pixotope is part of a major investment in our virtual production facilities,” says Dr. Tom Bradshaw, Employer Engagement & Employability Lead, University of Gloucestershire School of Creative Industries. Working with industry is something we do every day to ensure that our curricula are up to date, that our students have the latest industry insights, and that industry in turn has access to our bright and creative students. The success, impact, and enrichment of the program are owed to the participation of world-class educational institutions as well as esteemed industry partners, like leading U.K.-based virtual production studio, The Level. Kevin Cooney, Founder at The Level says, “The Pixotope Education Program is an exciting initiative because we can tap our network to help fill in the gaps and prepare students for their career. There’s so much learning happening every day in virtual production; we’re still fleshing out job titles and roles across the industry so I can only imagine how challenging it must be for educators to keep pace. Looking ahead, University of Gloucestershire plans to work with Pixotope to develop a Masters programme as another pathway to building the virtual production talent pipeline. Bradshaw concludes, "The jobs market in the creative industries does not stand still and nor do we. Through our education partnership with Pixotope, we are preparing our students to be in the best possible position for securing the best graduate jobs of the future.”
Pixotope is at the forefront of democratizing virtual production and empowering content creators with accessible software solutions for boundary-pushing immersive storytelling. Proven on the most demanding productions in the world, Pixotope offers media content owners and producers a reliable and sustainable Virtual Production Platform for real-time Augmented Reality, Extended Reality and Virtual Sets.